GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ImmunoPrecise Antibodies Ltd (NAS:IPA) » Definitions » FCF Margin %

ImmunoPrecise Antibodies (ImmunoPrecise Antibodies) FCF Margin % : -8.05% (As of Jan. 2024)


View and export this data going back to 2011. Start your Free Trial

What is ImmunoPrecise Antibodies FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. ImmunoPrecise Antibodies's Free Cash Flow for the three months ended in Jan. 2024 was $-0.37 Mil. ImmunoPrecise Antibodies's Revenue for the three months ended in Jan. 2024 was $4.64 Mil. Therefore, ImmunoPrecise Antibodies's FCF Margin % for the quarter that ended in Jan. 2024 was -8.05%.

As of today, ImmunoPrecise Antibodies's current FCF Yield % is -10.08%.

The historical rank and industry rank for ImmunoPrecise Antibodies's FCF Margin % or its related term are showing as below:

IPA' s FCF Margin % Range Over the Past 10 Years
Min: -103.21   Med: -48.88   Max: -11.31
Current: -19.3


During the past 13 years, the highest FCF Margin % of ImmunoPrecise Antibodies was -11.31%. The lowest was -103.21%. And the median was -48.88%.

IPA's FCF Margin % is ranked better than
69.59% of 1039 companies
in the Biotechnology industry
Industry Median: -144 vs IPA: -19.30


ImmunoPrecise Antibodies FCF Margin % Historical Data

The historical data trend for ImmunoPrecise Antibodies's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ImmunoPrecise Antibodies FCF Margin % Chart

ImmunoPrecise Antibodies Annual Data
Trend Dec13 Dec14 Dec15 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -35.25 -13.99 -11.31 -57.72 -103.21

ImmunoPrecise Antibodies Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -73.29 -47.97 -14.72 -8.67 -8.05

Competitive Comparison of ImmunoPrecise Antibodies's FCF Margin %

For the Biotechnology subindustry, ImmunoPrecise Antibodies's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ImmunoPrecise Antibodies's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ImmunoPrecise Antibodies's FCF Margin % distribution charts can be found below:

* The bar in red indicates where ImmunoPrecise Antibodies's FCF Margin % falls into.



ImmunoPrecise Antibodies FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

ImmunoPrecise Antibodies's FCF Margin for the fiscal year that ended in Apr. 2023 is calculated as

FCF Margin=Free Cash Flow (A: Apr. 2023 )/Revenue (A: Apr. 2023 )
=-15.818/15.326
=-103.21 %

ImmunoPrecise Antibodies's FCF Margin for the quarter that ended in Jan. 2024 is calculated as

FCF Margin=Free Cash Flow (Q: Jan. 2024 )/Revenue (Q: Jan. 2024 )
=-0.373/4.635
=-8.05 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ImmunoPrecise Antibodies FCF Margin % Related Terms

Thank you for viewing the detailed overview of ImmunoPrecise Antibodies's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


ImmunoPrecise Antibodies (ImmunoPrecise Antibodies) Business Description

Traded in Other Exchanges
Address
3204 - 4464 Markham Street, Victoria, BC, CAN, V8Z 7X8
ImmunoPrecise Antibodies Ltd is a supplier of custom antibodies to the research industry and industrial community. The company has aggregated its operations into one reportable segment, Antibody Production, and Related Services. It operates in three principal geographical areas - the United States of America, Canada, Europe, and others. The majority of its revenue is derived from Europe.